Heart Failure
Fresh Produce
Finerenone Meets Primary Endpoint in Phase III Study
Finerenone Meets Primary Endpoint in a Phase III cardiovascular outcomes study, Bayer recently announced the positive results from its Phase III FINEARTS-HF study, which evaluated the efficacy and safety of finerenone in patients with heart failure with mildly reduced...
Latest News
Brown-Forman Announces Restructuring and Workforce Changes
The whiskey producer Jack Daniel’s Tennessee Whiskey, Brown-Forman Corporation, has rolled out a strategic restructuring plan to enhance productivity...